 |
|
 |
|
| Abstracts are numbered according to the chronology of the 20th World Congress of Dermatology 2002 Scientific Sessions and are also codified according to the type of session they belong to. |
| The codification of the different types of sessions is as follows : |
|
|
|
|
|
|
CC: Clinical Cases
CO: Courses
IC: Interactives
P: Poster sessions
PL: Plenary sessions (Plenary lectures, Advances and Hot spots) |
|
|
SA: Satellite Symposia
SP: Sponsored Symposia
SY: Symposia
WK: Workshops
WN: What's New ? |
|
|
|
|
|
|
|
|
|
Clinical Cases |
|
|
Adverse drug reactions, internal medicine, paediatric dermatology (CC0777 - CC0801)
|
|
|
Courses |
|
|
Dermatopathology
|
|
|
Genetics and the skin (CO0844 - CO0853)
|
|
|
Interactives |
|
|
Acne (IC0765 - IC0770)
|
|
|
Dermatological surgery and lasers (part I) (IC0771 - IC0776)
|
|
|
Melanoma (part I) (IC0854 - IC0862)
|
|
|
Dermatological surgery and lasers (part II) (IC0863 - IC0870)
|
|
|
Mycoses (part I) (IC0876 - IC0883)
|
|
|
Melanoma (part II) (IC0884 - IC0889)
|
|
|
Dermatological surgery and laser (part III) (IC0890 - IC0897)
|
|
|
Melanoma (part III) (IC1017 - IC1022)
|
|
|
Dermatological surgery and laser (part IV) (IC1023 - IC1028)
|
|
|
Mycoses (part IV) (IC1029 - IC1036)
|
|
|
Plenary sessions |
|
|
Special lecture (PL0871)
|
|
|
Advances (PL0872 - PL0873)
|
|
|
Hot spots (PL0874 - PL0875)
|
|
|
Satellite Symposia |
|
|
LA ROCHE-POSAY LABORATOIRE PHARMACEUTIQUE: Cosmetics in acne treatments (SA1037 - SA1041)
|
|
|
ALLERGAN: Innovations with botulinum toxin type A: a foundation for facial enhancement (SA1042 - SA1045)
|
|
|
GALDERMA: Recent advances in psoriasis therapy (SA1046 - SA1050)
|
|
|
3M PHARMACEUTICAL: Cutaneous oncology: research with immune response modifiers (SA1051 - SA1055)
|
|
|
Sponsored Symposia |
|
|
LA ROCHE-POSAY LABORATOIRE PHARMACEUTIQUE: Photoprotection (SP0839 - SP0843)
|
|
|
GALDERMA: Improving the treatment of inflammatory acne (SP0954 - SP0959)
|
|
|
Symposia |
|
|
Diseases of the oral mucosa (SY0802 - SY0809)
|
|
|
History of dermatology (SY0810 - SY0819)
|
|
|
AIDS
|
|
|
Psoriasis (SY0820 - SY0826)
|
|
|
Retinoids (SY0827 - SY0831)
|
|
|
Experimental therapies for skin cancer (SY0832 - SY0838)
|
|
|
Photoimmunology (SY0960 - SY0969)
|
|
|
Vitiligo (SY0970 - SY0980)
|
|
|
Medical advances arising from dermatological research (SY0981 - SY0986)
|
|
|
Hair diseases (SY0987 - SY0993)
|
|
|
Paediatric dermatology (SY0994 - SY1004)
|
|
|
Urticaria (SY1005 - SY1010)
|
|
|
Workshops |
|
|
Tissue engineering (WK0707 - WK0713)
|
|
|
Thalidomide in dermatology (WK0714 - WK0721)
|
|
|
Acquired and congenital melanocytic nevi (WK0722 - WK0729)
|
|
|
Controversies in contact dermatitis: fragrance, latex, corticoids and others (WK0730 - WK0737)
|
|
|
New diseases, are they new? Are they true? (WK0738 - WK0746)
|
|
|
Liposuction and lipoinjection (WK0747 - WK0758)
|
|
|
L'OR?AL RECHERCHE: Black skin dermatology (WK0759 - WK0764)
|
|
|
The scope of dermatology: definition and borders (WK0898 - WK0910)
|
|
|
Quality of life issues and treatment compliance in dermatology (WK0911 - WK0922)
|
|
|
Cryosurgery (WK0923 - WK0931)
|
|
|
Traditional medicines (WK0932 - WK0936)
|
|
|
Dermatoses of pregnancy (WK0937 - WK0944)
|
|
|
Kaposi sarcoma (WK0945 - WK0953)
|
|
|
What's New ? |
|
|
Clinical dermatology, dermato-epidemiology, dermato-allergology, dermatologic surgery, genetic dermatology, nail disorders (WN1011 - WN1016)
|
